Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 3.

Journal Article

Boyle, Michael P., Bell, Scott C., Konstan, Michael W., McColley, Susanna A., Rowe, Steven M., Rietschel, Ernst, Huang, Xiaohong, Waltz, David, Patel, Naimish R. and Rodman, David (2014). A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial. Lancet Resp. Med., 2 (7). S. 527 - 539. OXFORD: ELSEVIER SCI LTD. ISSN 2213-2600

Kerem, Elton, Konstan, Michael W., De Boeck, Kris, Accurso, Frank J., Sermet-Gaudelus, Isabelle, Wilschanski, Michael, Elborn, J. Stuart, Melotti, Paola ORCID: 0000-0002-5276-1595, Bronsveld, Inez, Fajac, Isabelle ORCID: 0000-0002-1532-1486, Malfroot, Anne, Rosenbluth, Daniel B., Walker, Patricia A., McColley, Susanna A., Knoop, Christiane, Quattrucci, Serena, Rietschel, Ernst, Zeitlin, Pamela L., Barth, Jay, Elfring, Guy L., Welch, Ellen M., Branstrom, Arthur, Spiegel, Robert J., Peltz, Stuart W., Ajayi, Temitayo and Rowe, Steven M. (2014). Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial. Lancet Resp. Med., 2 (7). S. 539 - 548. OXFORD: ELSEVIER SCI LTD. ISSN 2213-2600

Rowe, Steven M., McColley, Susanna A., Rietschel, Ernst, Li, Xiaolei, Bell, Scott C., Konstan, Michael W., Marigowda, Gautham, Waltz, David and Boyle, Michael P. (2017). Lumacaftor/Ivacaftor Treatment of Patients with Cystic Fibrosis Heterozygous for F508del-CFTR. Ann. Am. Thoracic Society, 14 (2). S. 213 - 220. NEW YORK: AMER THORACIC SOC. ISSN 2325-6621

This list was generated on Fri Mar 29 06:10:46 2024 CET.